Search Results 11-20 of 17270 for GLP-1 therapy

1. A Study Of GLP-1 Receptor Agonists On Reproductive Health In Women - Mayo Clinic

   By condition, treatment or drug name. Search tips. A Study Of GLP-1 Receptor ... GLP-1 agonists during their reproductive years. To understand the efficacy each ...

2. Diabetes treatment: Medications for type 2 diabetes - Mayo Clinic

   Tirzepatide (Mounjaro), a similar kind of medicine called a dual-acting GLP-1/GIP agonist. Action. Cause the release of insulin as blood sugar levels are ...

3. Evaluation of the changes in glycemic and physiologic parameters (sleep, cardioadapatbility parameters) in non-diabetic patients being treated for obesity with GLP1 Agonist and GLP-1/ GIP agonist medications. - Mayo Clinic

   ... GLP1 Agonist and GLP-1/ GIP agonist medications. Print details. Share ... treatment to six months after in an effort to identify the predictors of treatment ...

4. Mayo Clinic Minute: Using combined therapy to treat obesity INTRO: Research shows that metabolic surgery and GLP-1 medications a

   INTRO: Research shows that metabolic surgery and GLP-1 medications are both effective therapies for treating obesity. Medications typically result in a 10% loss ...

5. Genetic test predicts response to weight-loss drugs - Mayo Clinic News Network

   ... treatment success. The findings, published in ... Yet treatment decisions often rely on simple ... GLP-1 drug, liraglutide (Saxenda). They found ...

6. A Study To Determine The Effects Of Blocking The Receptors Of GLP-1 On Appetite After Bariatric Surgery - Mayo Clinic

   A Study To Determine The Effects Of Blocking The Receptors Of GLP-1 On Appetite After Bariatric Surgery ... treatment works better than the current standard ...

7. Effect of GLP-1 Receptor Agonism After Sleeve Gastrectomy - Mayo Clinic

   ... treatment works better than the current standard therapy. ... Both RYGB and SG increase GLP-1 concentrations which directly affect B-cell function. ... GLP-1 is ...

8. Endogenous GLP-1 Secretion on Islet Function in People With and Without Type 2 Diabetes - Mayo Clinic

   ... 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market. Study IDs. Site IRB.

9. Using technology to remove barriers to bariatric surgery - Mayo Clinic

   In the end, one-third of participants underwent bariatric surgery; one-third chose treatment with GLP-1 RAs; and one-third were lost to follow-up during the ...

10. Obesity - Diagnosis and treatment - Mayo Clinic

    Also approved by the FDA is a class of drugs known as glucagonlike peptide 1 agonists, also called GLP-1 agonists. Some of these medicines are approved ...